BGU (Israel): New Fertility Treatment for Men and Women

BGN Technologies, Ben-Gurion University of the Negev’s technology transfer company, announced that BGU researchers are developing a new, single-dose fertility treatment based on a new telomerase-activating compound, which could improve both male and female fertility. The groundbreaking technology was developed by Prof.…